If you're considering semaglutide therapy, combining biomarker assessment with genetic context can help you and your provider make data-informed decisions about formulation, dose, and monitoring frequency
GLP1RAs have been associated with gallbladder-related events and rare pancreatitis in other settings [10,12] , underscoring the need for vigilance in real-world hepatology practice, particularly among patients with advanced fibrosis and multiple comorbidities
A study published Monday in Nature Medicine reaffirmed the growing consensus that the benefits of GLP-1 agonists like Wegovy and Ozempic might extend beyond protecting against diabetes or aiding in weight loss
This means that while we partner with licensed medical professionals for consultations and supervision, our commitment to transparent service ensures our approach remains consistent, providing clarity and support regardless of dosage changes
Patient-Centric Awareness Conduct free webinars & awareness camps on obesity and diabetes management